Veronica Finisguerra
Brussels, BRU, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Enhanced tumor response to adoptive T cell therapy with PHD2/3-deficient CD8 T cells.
Journal: Nature communications
Published: October 12, 2023
Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression.
Journal: Journal for immunotherapy of cancer
Published: March 30, 2023
Preclinical murine tumor models: a structural and functional perspective.
Journal: eLife
Published: August 02, 2019
TGFβ blocks IFNα/β release and tumor rejection in spontaneous mammary tumors.
Journal: Nature communications
Published: June 20, 2018
Is There Merit for MET-Targeted Therapies in Gastroesophageal Cancer?
Journal: JAMA oncology
Published: September 15, 2017
Hypoxia determines survival outcomes of bacterial infection through HIF-1alpha dependent re-programming of leukocyte metabolism.
Journal: Science immunology
Published: April 08, 2017
Preclinical and clinical evaluation of MET functions in cancer cells and in the tumor stroma.
Journal: Oncogene
Published: November 27, 2015
MET is required for the recruitment of anti-tumoural neutrophils.
Journal: Nature
Published: June 13, 2013
Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment.
Journal: Oncogene
Published: January 28, 2013
Gene-targeting of Phd2 improves tumor response to chemotherapy and prevents side-toxicity.
Journal: Cancer cell
Published: October 12, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026